ストックスクリーナーアプリを入手
16.60
1.95%
-0.33
プレマーケット:
16.62
0.02
+0.12%
Nurix Therapeutics Inc (NRIX) 最新ニュース
Houte Hans Van Sells 14,055 Shares of Nurix Therapeutics (NASDAQ:NRIX) Stock - MarketBeat
Nurix CFO Hans van Houte sells $233k in company stock - Investing.com
Nurix Therapeutics (NRIX) CFO sells 14,055 shares in planned trade - Stock Titan
Insider Sell: Christine Ring Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
[144] Nurix Therapeutics, Inc. SEC Filing - Stock Titan
Nurix Therapeutics chief legal officer sells $138k in stock - Investing.com
Nurix Therapeutics (NRIX) CLO sells 8,148 shares in planned trade - Stock Titan
Form 144: Christine Ring to sell NRIX shares (NRIX) - Stock Titan
(NRIX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock - Investing.com
Nurix Therapeutics (NRIX) legal chief sells 5,394 shares in planned trade - Stock Titan
Issuer (NASDAQ: NRIX) reports proposed RSU sale by executive - Stock Titan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares By Investing.com - Investing.com Australia
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 Shares - MarketBeat
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of Stock - MarketBeat
Nurix therapeutics CSO Hansen sells $53,497 common stock - Investing.com UK
Nurix therapeutics CSO Hansen sells $53,497 common stock By Investing.com - Investing.com India
Nurix therapeutics CFO Hans van Houte sells $39,748 in shares By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares - Investing.com
Nurix (NRIX) CFO nets shares after RSU vesting tax sale - Stock Titan
Tax-driven share sale and RSU vesting for Nurix (NRIX) - Stock Titan
Nurix (NRIX) CSO Hansen converts RSUs, sells 3,214 shares to cover taxes - Stock Titan
Pictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
California Biopharma Co. Uncovers Massive Oncology Breakthrough - Streetwise Reports
Nurix Therapeutics shares edge higher despite Q1 earnings miss - MSN
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - MSN
Institutional Investors Accumulate Nurix Therapeutics Stock on TPD Leadership - HarianBasis.co
Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money - Insider Monkey
NRIX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $32 - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Nurix stock, $32 target - Investing.com UK
H.C. Wainwright reiterates Buy on Nurix stock, $32 target By Investing.com - Investing.com Australia
Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential - Insider Monkey
Assessing Nurix Therapeutics (NRIX) Valuation After New AACR 2026 Oncology Data - Sahm
Redmile (NRIX) holds 10.7M shares — 9.9% including warrants - Stock Titan
Nurix Therapeutics (NRIX) Receives a Buy from Piper Sandler - The Globe and Mail
Does Nurix Therapeutics (NRIX) have the potential to rally 85.84% as Wall Street analysts expect? - MSN
NRIX Reiterates by Needham -- Price Target Maintained at $26 - GuruFocus
Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):